RESUMEN
BACKGROUND: Some evidence suggests substance use affects clinical outcomes in people with posttraumatic stress disorder (PTSD). However, more work is required to examine links between mental health and cannabis use in PTSD during exposure to external stressors such as the COVID-19 pandemic. This study assessed mental health factors in individuals with self-reported PTSD to: (a) determine whether stress, anxiety, and depression symptoms were associated with changes in cannabis consumption across the pandemic, and (b) to contrast the degree to which clinically significant perceived symptom worsening was associated with changes in cannabis intake. METHOD: Data were obtained as part of a larger web-based population survey from April 3rd to June 24th 2020 (i.e., first wave of the pandemic in Canada). Participants (N = 462) with self-reported PTSD completed questionnaires to assess mental health symptoms and answered questions pertaining to their cannabis intake. Participants were categorized according to whether they were using cannabis or not, and if using, whether their use frequency increased, decreased, or remained unchanged during the pandemic. RESULTS: Findings indicated an overall perceived worsening of stress, anxiety, and depression symptoms across all groups. A higher-than-expected proportion of individuals who increased their cannabis consumption reached threshold for minimal clinically important worsening of depression, X2(3) = 10.795, p = 0.013 (Cramer's V = 0.166). CONCLUSION: Overall, those who increased cannabis use during the pandemic were more prone to undergo meaningful perceived worsening of depression symptoms. Prospective investigations will be critical next steps to determine the directionality of the relationship between cannabis and depressive symptoms.
Asunto(s)
COVID-19 , Cannabis , Depresión , Trastornos por Estrés Postraumático , Humanos , Ansiedad/epidemiología , Cannabis/efectos adversos , Depresión/complicaciones , Depresión/epidemiología , Pandemias , Trastornos por Estrés Postraumático/complicaciones , Trastornos por Estrés Postraumático/epidemiología , Trastornos por Estrés Postraumático/psicología , Estudios RetrospectivosRESUMEN
OBJECTIVE: In this population-based cohort study, we examined the association between the presence of symptomatic osteoarthritis (OA) and risk for cardiovascular (CV) events. METHOD: A cohort aged ≥55 years recruited from 1996 to 98 was followed through provincial health administrative data to 2014. Demographics, joint complaints and functional limitations were collected. Hip, knee and hand OA were defined using a validated definition. Using Cox-regressions, the relationship between OA and a composite CV outcome (myocardial infarction (MI), stroke, angina, heart failure, revascularization) was assessed controlling for age, body mass index (BMI), sex, pre-existing metabolic factors, comorbidities, income status, primary care exposure and functional limitations. RESULTS: 18,490 participants were included: median age was 68 years, 60.3% were female; 24.4% met criteria for OA (10.0% hip, 15.3% knee, 16.0% hand), 16.3% self-reported limitation in grip and 25.4% in walking. Over a median 13.4 years, 31.9% experienced a CV event. Controlling for all but walking limitation, a dose-response relationship was observed between number of joints affected by knee/hip OA and CV risk (HR 2 hips/knees vs none: 1.13, 95% CI 1.03-1.23; 3+ hips/knees: 1.22, 95% CI 1.09-1.36). This relationship became non-significant additionally controlling for difficulty walking. Self-reported difficulty walking was associated with a 30% increased hazard for CV events. The effect of hand OA was not significant. CONCLUSION: In a large population cohort, a greater burden of hip/knee OA was associated with higher CV risk; the relationship was explained by OA-related difficulty walking. Increased attention to management of OA with a view to improving mobility has potential to reduce CV events.
Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Revascularización Miocárdica/estadística & datos numéricos , Osteoartritis de la Cadera/epidemiología , Osteoartritis de la Rodilla/epidemiología , Atención Primaria de Salud , Anciano , Angina de Pecho/epidemiología , Estudios de Cohortes , Servicio de Urgencia en Hospital , Femenino , Articulaciones de la Mano , Insuficiencia Cardíaca/epidemiología , Hospitalización , Humanos , Renta , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Limitación de la Movilidad , Infarto del Miocardio/epidemiología , Ontario/epidemiología , Osteoartritis/epidemiología , Osteoartritis/fisiopatología , Osteoartritis de la Cadera/fisiopatología , Osteoartritis de la Rodilla/fisiopatología , Modelos de Riesgos Proporcionales , Factores Sexuales , Accidente Cerebrovascular/epidemiologíaRESUMEN
INTRODUCTION: There is little information on recent trends in the economic burden of asthma. Our objective was to estimate the excess costs of asthma and their trend in British Columbia, Canada, from 2002 to 2011. METHODS: A retrospective cohort of individuals aged 5-55 years was constructed from the provincial administrative health databases, consisting of patients with physician-diagnosed asthma and a propensity-score-matched comparison sample from the general population. Total direct medical costs were calculated as the sum of hospitalizations, outpatient visits and medication costs, adjusted to 2012 Canadian dollars ($). Excess costs were defined as the difference in costs between the asthma and comparison groups. RESULTS: A total of 341 457 individuals (mean age at entry 27.3, 54.1% female) were equally divided into the asthma and comparison groups. Excess costs in patients with asthma were $1028.0 (95% CI $982.7-$1073.4) per patient-year (PY). Medications contributed to the greatest share of excess costs ($471.7/PY), whereas hospitalization and outpatient costs were, respectively, $272.2/PY and $284.1/PY. Only $192.9/PY was attributable to asthma itself. There was a 2.9%/year increase in excess costs (P < 0.001), a combination of asthma-attributable costs declining by 0.8%/year while nonasthma excess costs increasing by 3.8%/year. The most dramatic trend was observed in asthma-related outpatient costs, which decreased by %6.6/year. CONCLUSIONS: A significant share of excess costs in asthma is not attributable to the disease itself. The pattern of costs changed significantly during the study period. The burden of comorbid conditions should be considered in developing evidence-based policies for management of patients with asthma.
Asunto(s)
Asma/epidemiología , Costos de la Atención en Salud/estadística & datos numéricos , Costos de la Atención en Salud/tendencias , Vigilancia de la Población , Adolescente , Adulto , Niño , Preescolar , Costos de los Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores Socioeconómicos , Adulto JovenRESUMEN
OBJECTIVES: To examine the effect of Osteoarthritis (OA)-related difficulty walking on risk for diabetes complications in persons with diabetes and OA. DESIGN: A population cohort aged 55+ years with symptomatic hip and knee OA was recruited 1996-98 and followed through provincial administrative data to 2015 (n = 2,225). In those with confirmed OA (examination and radiographs) and self-reported diabetes at baseline (n = 359), multivariate Cox regression modeling was used to examine the relationship between baseline difficulty walking (Health Assessment Questionnaire (HAQ) difficulty walking score; use of walking aid) and time to first diabetes-specific complication (hospitalization for hypo- or hyperglycemia, infection, amputation, retinopathy, or initiation of chronic renal dialysis) and cardiovascular (CV) events. RESULTS: Participants' mean baseline age was 71.4 years; 66.9% were female, 77.7% had hypertension, 54.0% had pre-existing CV disease, 42.9% were obese and 15.3% were smokers. Median HAQ difficulty walking score was 2/3 indicating moderate to severe walking disability; 54.9% used a walking aid. Over a median 6.1 years, 184 (51.3%) experienced one or more diabetes-specific complications; 191 (53.2%) experienced a CV event over a median 5.7 years. Greater baseline difficulty walking was associated with shorter time to the first diabetes-specific complication (adjusted HR per unit increase in HAQ walking 1.24, 95% CI 1.04-1.47, P = 0.02) and CV event (adjusted HR for those using a walking aid 1.35, 95% CI 1.00-1.83, P = 0.04). CONCLUSIONS: In a population cohort with OA and diabetes, OA-related difficulty walking was a significant - and potentially modifiable - risk factor for diabetes complications.
Asunto(s)
Complicaciones de la Diabetes/etiología , Limitación de la Movilidad , Osteoartritis de la Cadera/complicaciones , Osteoartritis de la Rodilla/complicaciones , Caminata , Anciano , Femenino , Humanos , Masculino , Modelos de Riesgos Proporcionales , Factores de Riesgo , Encuestas y CuestionariosRESUMEN
Restless legs syndrome (RLS) is a common sleep disorder that may be associated with pregnancy. Studies have found that the prevalence of RLS among pregnant women ranged from 10 to 34%. Typically, there is complete remission of symptoms soon after parturition; however, in some patients, they may continue postpartum. RLS has been shown to be associated with a number of complications in pregnancy including preeclampsia and increased incidence of Cesarean sections. Although multiple hypotheses have been proposed to explain this association, each individual hypothesis cannot completely explain the whole pathogenesis. Present understanding suggests that a strong family history, low serum iron and ferritin level, and high estrogen level during pregnancy might play important roles. Vitamin D deficiency and calcium metabolism may also play a role. Medical treatment of RLS during pregnancy is difficult and challenging considering the risks to mother and fetus. However, in some cases, the disease may be severe enough to require treatment.
Asunto(s)
Complicaciones del Embarazo/epidemiología , Síndrome de las Piernas Inquietas/epidemiología , Femenino , Humanos , Incidencia , Embarazo , Complicaciones del Embarazo/terapia , Prevalencia , Síndrome de las Piernas Inquietas/terapiaRESUMEN
OBJECTIVE: To examine the association between osteoarthritis (OA) pain characteristics and symptom acceptability. DESIGN: Using a cross-sectional study design in a knee OA cohort we assessed socio-demographics, knee pain characteristics (Intermittent and Constant Osteoarthritis Pain (ICOAP); higher scores worse), frequency of intermittent pain 'without warning' (unpredictable) or 'after a trigger' (predictable) (never to very often) and the acceptability of knee pain symptoms (yes/no). Using logistic regression, we examined the relationship between pain characteristics and symptom acceptability. RESULTS: 136 cohort members' participated (mean age 74 years, SD 9.5; 54% female). Most (97%) reported intermittent pain (mean ICOAP intermittent score 36.8, SD 19.7) and 62 (46%) reported constant pain (mean ICOAP constant score 46.7, SD 20.2). Of those with intermittent pain, 42% reported frequent (often/very often) predictable pain and 27% frequent unpredictable pain. 35% reported "unacceptable" knee symptoms. In multivariable analysis, the odds of reporting an unacceptable symptom state increased with increasing intermittent knee pain scores and the effect was greater for those with vs without frequent unpredictable intermittent pain (adjusted OR per 10-point increase in ICOAP intermittent score 3.31, 95% confidence interval (CI) 1.38-7.97 vs 1.23, 95%CI 0.88-1.74, respectively; P value for the interaction = 0.03). CONCLUSION: In a community cohort with symptomatic knee OA, both the severity and predictability of intermittent knee pain contributed to symptom state acceptability. Unpredictable intermittent knee pain was more likely to be associated with an unacceptable symptom state than predictable intermittent pain. Research is warranted to elucidate potentially modifiable determinants of unpredictable intermittent pain in people with knee OA.